Clinical Trials Directory

Trials / Completed

CompletedNCT05435573

Cardiac Output in Preeclamptic

Coload Effect on Cardiac Output Measurement Using Transthoracic Echocardiography in Preeclamptic Patients Undergoing Cesarean Delivery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Mansoura University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

There is high incidence of hypertensive disorders during pregnancy.The maternal cardiovascular system had significant changes during pregnancy. The colloid oncotic pressure is decreased during preeclampsia.

Detailed description

Transthoracic echocardiography considered an accurate non-invasive device and has validity for measuring cardiac functions in pregnancy.

Conditions

Interventions

TypeNameDescription
DRUG1000 mL of ringer's acetate solution1000 mL of ringer's acetate solution
DRUG250 mL 6% hydroxyethyl starch (Voluven) then 500 mL of ringer's acetate solution then 250 mL of 6% hydroxyethyl starch (Voluven)500 mL 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride plus 500 mL of ringer's acetate solution

Timeline

Start date
2022-08-17
Primary completion
2023-09-15
Completion
2024-06-03
First posted
2022-06-28
Last updated
2026-02-17

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05435573. Inclusion in this directory is not an endorsement.